IDEAS logo
IDEAS-lightbulb

IDEAS welcomes AstraZeneca to our H2020 project

IDEAS would like to welcome AstraZeneca to our innovative training network as a partner.

Project spotlight:

7. Subgroup Analyses in Early Phase Clinical Trials

In many instances during drug development, question arises “Is it worth proceeding?” This often implies evaluations of “probability of success” (PoS) at a later stage, given the current knowledge.

[ see all projects ]